Русский / English
Enter the query
Events
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Calendar
prev April 2019
Mon Tue Wed Thu Fri Sat Sun
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30
26.01.2015
Petrovax Pharm is selling products as part of a joint partnership with LLC Vaga Pharm, a medication supplier on the Armenian market.
More Topics Petrovax Pharm
11.12.2014
Extraordinary General Meeting of Shareholders of MMC Norilsk Nickel held on December 11 approved dividend payments for 9M 2014 in the amount of RUB 762.34 per ordinary share.
More Topics Norilsk Nickel / Potanin / Interros
28.07.2014
According to Orange Book, a regular report by Synergy Research Group, Petrovax Pharm has become one of the Top 5 companies by number of clinical trials started in Q2 2014 in the Russian pharmaceuticals market.
More Topics Petrovax Pharm
12.05.2014
The immunobiological production unit of NPO Petrovax Pharm, a Russian pharmaceutical company, has produced more than 2.5 mln doses of Prevenar 13, a 13-valent conjugate pneumococcal vaccine, in easy to use disposable auto injectors. More than 5 mln doses are planned to be produced by the end of 2014.
More Topics Petrovax Pharm
26.03.2014
On March 26, 2014, NPO Petrovax Pharm ran a media tour for key business and industry journalists at the Company's production site in the Podolsk District of Moscow Region. The journalists were taken on a tour around the unique facility where 13-valent conjugate pneumococcal vaccine is produced.
More Topics Petrovax Pharm